Power Law company profile

Alector

Biotech & Life Sciences · San Francisco, United States · Founded 2013 · IPO 2019 Unicorn

Combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel

Valuation

$44M

Market cap · May/2026

Revenue

$21M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

17 investors on Alector's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 2 investors entered at this stage

Polaris Partners

OrbiMed

Series B+ 15 investors entered at this stage

New Leaf Venture Partners

SV Health Investors

Abbvie Biotech Ventures

Casdin Capital

Euclidean Capital

MRL Ventures

Lilly Asia Ventures

Mission Bay Capital

Foresite Capital

Perceptive Advisors

Section 32

Federated Hermes

Amgen Ventures

Dementia Discovery Fund

Global footprint

Where Alector has talent and traffic

AI talent share

1.9% of workforce is AI talent
(3 of 154 staff)

Core AI10.65%

Other AI21.3%

Non-AI workforce15198.05%

Workforce by country

3 countries with
team presence

🇺🇸 United States98.3%

🇦🇷 Argentina1.4%

🇦🇺 Australia0.7%

3 countries shown

Web traffic by country

12K monthly visits
across markets

🇺🇸 United States52.5%

🇱🇻 Latvia28.3%

🇮🇳 India17.5%

🇩🇪 Germany2.5%

🇨🇦 Canada0%

Top 5 markets shown

Patent intelligence

$93M patent portfolio · 67 active families

Estimated portfolio value

$93M

210.9% of market cap · 8.4× smaller than top peer BioNTech ($780M)

67 active patent families

Where Alector innovates Molecular biologyAntiendomysial antibodiesAntibody fragmentsMonoclonalAnti antibody

Where Alector concentrates vs peers

Each axis is a top-10 topic across Alector and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Alector

An AI-synthesized read of the highest-engagement posts about Alector on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Alector on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles